Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Schramm, A*" or (type exact bookEditor and editor="Schramm, A*")

Add to list
- Journal Article
- A1
- open access
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

Johannes H Schulte, Tobias Marschall, Marcel Martin, Philipp Rosenstiel, Pieter Mestdagh (UGent) , Stefanie Schlierf, Theresa Thor, Jo Vandesompele (UGent) , Angelika Eggert, Stefan Schreiber, et al.

(2010) NUCLEIC ACIDS RESEARCH. 38(17). p.5919-5928
Add to list
- Journal Article
- A1
- open access
The miR-17-92 MicroRNA Cluster regulates multiple components of the TGF-beta Pathway in neuroblastoma

Pieter Mestdagh (UGent) , Anna-Karin Bostrom, Francis Impens (UGent) , Erik Fredlund, Gert Van Peer (UGent) , Pasqualino De Antonellis, Kristoffer von Stedingk, Bart Ghesquière (UGent) , Stefanie Schulte, Michael Dews, et al.

(2010) MOLECULAR CELL. 40(5). p.762-773
Add to list
- Conference Paper
- C3
Pharmacologic activation of the P53 pathway by Nutlin-3 inhibits medulloblastoma cell proliferation in vitro

Annette Kuenkele, Katleen De Preter (UGent) , Jo Vandesompele (UGent) , Kristian Pajtler, Lukas Heukamp, Michael Grotzer, Alexander Schramm, Angelika Eggert and Johannes Schulte

(2010) PEDIATRIC BLOOD & CANCER. 55(5). p.918-918
Add to list
- Conference Paper
- C3
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

Johannes Schulte, Benjamin Schowe, Pieter Mestdagh (UGent) , Lars Kaderali, Prabhav Kalaghatgi, Stefanie Schlierf, Joëlle Vermeulen (UGent) , Bent Brockmeyer, Kristian Pajtler, Theresa Thor, et al.

(2010) PEDIATRIC BLOOD & CANCER. 55(5). p.812-812
Add to list
- Conference Paper
- C3
High expression of the ALK receptor tyrosine kinase precedes mutation as a determining factor of unfavourable phenotype in primary neuroblastoma

Johannes Schulte, Hagen Bachmann, Bent Brockmeyer, Sandra Nowacki, Yvonne Kahlert, Andre Oberthur, Katleen De Preter (UGent) , Kristian Pajtler, Jessica Theissen, Frank Westermann, et al.

(2010) PEDIATRIC BLOOD & CANCER. 55(5). p.827-827
Add to list
- Conference Paper
- C3
Deep sequencing reveals differential expression of microRNAs in favourable versus unfavourable neuroblastoma

Johannes Schulte, Tobias Marshall, Marcel Martin, Philipp Rosenstiel, Pieter Mestdagh (UGent) , Stefanie Schlierf, Theresa Thor, Jo Vandesompele (UGent) , Angelika Eggert, Stefan Schreiber, et al.

(2010) PEDIATRIC BLOOD & CANCER. 55(5). p.826-827
Add to list
- Journal Article
- A1
Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds

Katleen De Preter (UGent) , Sara De Brouwer (UGent) , Tom Van Maerken (UGent) , Filip Pattyn (UGent) , A Schramm, A Eggert, Jo Vandesompele (UGent) and Franki Speleman (UGent)

(2009) CLINICAL CANCER RESEARCH. 15(11). p.3690-3696
Add to list
- Conference Paper
- C3
The miR-17-92 gene cluster is amplified and overexpressed in retinoblastoma

E Biewald, Pieter Mestdagh (UGent) , H Stephan, Katleen De Preter (UGent) , T Thor, M Baumann, D Lohmann, A Eggert, Franki Speleman (UGent) , A Schramm, et al.

(2009) KLINISCHE PADIATRIE. 221(3).
Add to list
- Conference Paper
- C3
Modeling neuroblastomagenesis from neural crest stem cells in vitro and in vivo

J Schulte, A Bohrer, E Mahlow, J Maurer, H Schorle, Katleen De Preter (UGent) , Jo Vandesompele (UGent) , Franki Speleman (UGent) , S Schlierf, K Pajtler, et al.

(2009) PEDIATRIC BLOOD & CANCER. 53(5). p.703-704
Add to list
- Conference Paper
- C3
ALK Mutation Analysis in Patients of the German Neuroblastoma Study

B Brockmeyer, JH Schulte, A Oberthuer, Pieter Mestdagh (UGent) , K Pajtler, J Theissen, H Bachmann, B Hero, Jo Vandesompele (UGent) , F Berthold, et al.

(2009) KLINISCHE PADIATRIE. 221(3). p.195-195

← Previous

Academic Bibliography

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

The miR-17-92 MicroRNA Cluster regulates multiple components of the TGF-beta Pathway in neuroblastoma

Pharmacologic activation of the P53 pathway by Nutlin-3 inhibits medulloblastoma cell proliferation in vitro

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

High expression of the ALK receptor tyrosine kinase precedes mutation as a determining factor of unfavourable phenotype in primary neuroblastoma

Deep sequencing reveals differential expression of microRNAs in favourable versus unfavourable neuroblastoma

Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds

The miR-17-92 gene cluster is amplified and overexpressed in retinoblastoma

Modeling neuroblastomagenesis from neural crest stem cells in vitro and in vivo

ALK Mutation Analysis in Patients of the German Neuroblastoma Study

Contents

Support

Contact